Location History:
- Tokyo, JP (2020 - 2022)
- Chuo-ku, JP (2023 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: Ryu Oshima: Innovator in Pemafibrate Therapy
Introduction
Ryu Oshima is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the development of dosing regimens for pemafibrate therapy. With a total of seven patents to his name, Oshima's work is focused on improving patient safety and treatment efficacy.
Latest Patents
Oshima's latest patents revolve around pemafibrate dosing regimens. His innovations aim to provide a medicament that safely treats patients in need of pemafibrate therapy. The medicament includes strategies to avoid or suspend the concomitant use of pemafibrate with OATP1B inhibitors, which helps suppress an increase in plasma concentration of the drug. Additionally, he emphasizes the importance of reducing the dose of pemafibrate when necessary to ensure patient safety.
Career Highlights
Throughout his career, Ryu Oshima has worked with prominent companies such as Kowa Company Limited and Olympus Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in medical treatments.
Collaborations
Oshima has collaborated with notable professionals in his field, including Gary Gordon and Masatoshi Ito. These partnerships have further enhanced his research and development efforts, leading to impactful innovations in pemafibrate therapy.
Conclusion
Ryu Oshima's contributions to the field of medicine through his patents and collaborations highlight his commitment to improving patient care. His work in pemafibrate therapy exemplifies the importance of innovation in healthcare.